Cargando…

Year of Expanding into Circulating Biomarkers

This editorial article summarizes the achievements and current challenges for the Journal of Circulating Biomarkers (JCB) regarding a more strategic approach to branding and attracting a high quality variety of articles. More emphasis is placed on fostering engagement with academic and industry sour...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Shidong, Kuo, Winston Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580335/
https://www.ncbi.nlm.nih.gov/pubmed/28936237
http://dx.doi.org/10.5772/60126
_version_ 1783260889235849216
author Jia, Shidong
Kuo, Winston Patrick
author_facet Jia, Shidong
Kuo, Winston Patrick
author_sort Jia, Shidong
collection PubMed
description This editorial article summarizes the achievements and current challenges for the Journal of Circulating Biomarkers (JCB) regarding a more strategic approach to branding and attracting a high quality variety of articles. More emphasis is placed on fostering engagement with academic and industry sources operating at the cutting-edge of translational technologies applied to the field of circulating biomarkers (interface between extracellular vesicles including exosomes and microvesicles, circulating tumour cells, cell-free circulating DNA and circulating protein markers) and with those in the investment arena seeking and providing private funding for this area of research.
format Online
Article
Text
id pubmed-5580335
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-55803352017-09-21 Year of Expanding into Circulating Biomarkers Jia, Shidong Kuo, Winston Patrick J Circ Biomark Editorial This editorial article summarizes the achievements and current challenges for the Journal of Circulating Biomarkers (JCB) regarding a more strategic approach to branding and attracting a high quality variety of articles. More emphasis is placed on fostering engagement with academic and industry sources operating at the cutting-edge of translational technologies applied to the field of circulating biomarkers (interface between extracellular vesicles including exosomes and microvesicles, circulating tumour cells, cell-free circulating DNA and circulating protein markers) and with those in the investment arena seeking and providing private funding for this area of research. SAGE Publications 2015-01-29 /pmc/articles/PMC5580335/ /pubmed/28936237 http://dx.doi.org/10.5772/60126 Text en © 2015 The Author(s). Licensee InTech. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Jia, Shidong
Kuo, Winston Patrick
Year of Expanding into Circulating Biomarkers
title Year of Expanding into Circulating Biomarkers
title_full Year of Expanding into Circulating Biomarkers
title_fullStr Year of Expanding into Circulating Biomarkers
title_full_unstemmed Year of Expanding into Circulating Biomarkers
title_short Year of Expanding into Circulating Biomarkers
title_sort year of expanding into circulating biomarkers
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580335/
https://www.ncbi.nlm.nih.gov/pubmed/28936237
http://dx.doi.org/10.5772/60126
work_keys_str_mv AT jiashidong yearofexpandingintocirculatingbiomarkers
AT kuowinstonpatrick yearofexpandingintocirculatingbiomarkers